July 29, 2015 | Story Review

Story’s “one-two punch” for breast cancer could leave some women knocked out by side effects

This Washington Post article based on a news release is a bit skimpy on the details – no mention of costs, side effects, or study limitations. It also hypes the benefits of a drug combination that weren’t studied here and whose effectiveness is unknown.

 

3 Star

One-two punch of two generics for breast cancer may be more powerful than wonder drug tamoxifen

July 29, 2015 | Story Review

Evidence-based message on HPV vaccine would have benefited from more specifics

It’s hard to argue with the conclusion here, but the messaging would have been stronger with some numbers and an independent expert voice.

3 Star

Gardasil: Yup. Still Safe.

July 24, 2015 | Story Review 1

WSJ business story on Alzheimer’s drugs missed key aspects of health angle

This business story checked some of our boxes, but fell short on the key criteria that we think readers needed in this discussion of new Alzheimer’s drugs.

3 Star

Lilly’s Alzheimer’s Drug May Slow Patients’ Decline, Study Shows Separate study shows experimental Biogen drug also holds promise

July 23, 2015 | Story Review 1

A pill that neutralizes gluten? Fox rehash of a CBC story reflects polluted health news stream

A poor-quality news release spawned weak coverage from the CBC, which is paraphrased here by Fox with even less context and nuance. Failure on many levels.

1 Star

Pill may make pizza, pasta safe for gluten-free diners

Toolkit

Tips for Understanding Studies

View More

Toolkit

Story Reviews

Our team of reviewers applies 10 standardized criteria to news stories that include claims about health care interventions. ~2,000 reviews published.

Read More

News Release Reviews

We systematically evaluate the quality of health care-related news releases by journals, medical centers, drug/device makers, others.

Read More

Blog

Wide-ranging exploration of issues in journalism, journal publishing, health care PR, advertising and marketing. Some opinions - publisher Gary Schwitzer's & others'.

Read More